Status:
COMPLETED
Positive Affect as a Source of Resilience for Adults in Chronic Pain
Lead Sponsor:
Weill Medical College of Cornell University
Collaborating Sponsors:
National Institute on Aging (NIA)
Cornell University
Conditions:
Geriatric
Chronic Pain
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
Fibromyalgia syndrome (FMS) is a chronic musculoskeletal condition characterized by widespread pain and tenderness, and often accompanied by impaired physical functioning, depressed mood, as well as d...
Detailed Description
Specific Aims: Aim 1: To maximize relevance and acceptability of content and delivery of LARKSPUR intervention among patients with FMS, a chronic pain population with known deficits in PA. This aim w...
Eligibility Criteria
Inclusion
- Access to daily internet
- ≥ 50 years of age
- Able to read and understand English
- Physician diagnosis confirmation of FMS AND/OR Score ≥ 13 on the 6-item, self-report fibromyalgia screening tool
- Report having pain for at least the last three months
Exclusion
- Cognitive impairment
- Current behavioral treatment for pain
- Enrolled in another pain study
Key Trial Info
Start Date :
July 27 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 9 2022
Estimated Enrollment :
95 Patients enrolled
Trial Details
Trial ID
NCT04869345
Start Date
July 27 2021
End Date
June 9 2022
Last Update
May 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NewYork-Presbyterian - Weill Cornell Medicine
New York, New York, United States, 10065